Spots Global Cancer Trial Database for invasive bladder cancer

Every month we try and update this database with for invasive bladder cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Dose Escalation, Expansion Study of Vofatamab (B-701) in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma	NCT02401542	Locally Advance... Urinary Bladder... Urological Dise...	Vofatamab Docetaxel Placebo	18 Years -	Rainier Therapeutics
Intravenous Lidocaine for Cystectomy Procedures	NCT02924480	Invasive Bladde...	Cystectomy Lidocaine Saline	18 Years -	CAMC Health System
Intravenous Lidocaine for Cystectomy Procedures	NCT02924480	Invasive Bladde...	Cystectomy Lidocaine Saline	18 Years -	CAMC Health System
Atezolizumab and BCG in High Risk BCG naïve Non-muscle Invasive Bladder Cancer (NMIBC) Patients (BladderGATE)	NCT04134000	Invasive Bladde...	Atezolizumab BCG	18 Years -	Fundacion Oncosur
Multiparametric Magnetic Resonance Imaging Performance in Detection of Occult Muscle Invasion in Urinary Bladder Cancer	NCT05783271	Invasive Bladde...		-	Assiut University
Durvalumab Plus Tremelimumab With Concurrent Radiotherapy for Localized Muscle Invasive Bladder Cancer Treated With a Selective Bladder Preservation Approach	NCT03702179	Invasive Bladde...	Durvalumab Tremelimumab Radiotherapy	18 Years -	Spanish Oncology Genito-Urinary Group
Testing the Utilization of a Mobile Health App for Patients Undergoing Cystectomy Surgery for Bladder Cancer	NCT03862105	Invasive Bladde...	Mobile Health a...	18 Years - 100 Years	UNC Lineberger Comprehensive Cancer Center
Nordic Cystectomy Study III - Transfusion	NCT04537221	Bladder Cancer Invasive Bladde...	Blood transfusi...	18 Years -	Turku University Hospital
Pembrolizumab in Muscle Invasive/Metastatic Bladder Cancer	NCT02560636	Invasive Bladde...	Pembrolizumab Radiotherapy	18 Years -	Royal Marsden NHS Foundation Trust
Nordic Cystectomy Study II - Albumin	NCT04523038	Bladder Cancer Invasive Bladde...	S-Albumin	18 Years -	Turku University Hospital
Nordic Cystectomy Study II - Albumin	NCT04523038	Bladder Cancer Invasive Bladde...	S-Albumin	18 Years -	Turku University Hospital
Intravenous Lidocaine for Cystectomy Procedures	NCT02924480	Invasive Bladde...	Cystectomy Lidocaine Saline	18 Years -	CAMC Health System
Multiparametric Magnetic Resonance Imaging Performance in Detection of Occult Muscle Invasion in Urinary Bladder Cancer	NCT05783271	Invasive Bladde...		-	Assiut University
Pembrolizumab in Muscle Invasive/Metastatic Bladder Cancer	NCT02560636	Invasive Bladde...	Pembrolizumab Radiotherapy	18 Years -	Royal Marsden NHS Foundation Trust
A Study of Mitomycin-c/ Capecitabine ChemoRadiotherapy Combined With Nivolumab Monotherapy or Ipilumimab and Nivolumab, as Bladder Sparing Curative Treatment for Muscle Invasive Bladder Cancer: the CRIMI Study	NCT03844256	Urinary Bladder... Invasive Bladde...	nivolumab 480mg nivolumab 3mg/k... nivolumab 1mg/k...	18 Years -	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
HIPEC After Radical Cystectomy for High Risk Bladder Cancer	NCT03514888	Invasive Bladde...	HIPEC	45 Years - 85 Years	Weill Medical College of Cornell University
Nordic Cystectomy Study I - Neutrophil-lymphocyte Ratio (NLR)	NCT04523025	Bladder Cancer Invasive Bladde...	NLR-ratio	18 Years -	Turku University Hospital

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: